Wenling Zhang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 18
- RNA Research and Splicing 10
- Circular RNAs in diseases 7
- Cancer-related gene regulation 6
-
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 12
- Co-authors
- Guiyuan Li (51 shared papers)Zhaoyang Zeng (35 shared papers)Xiayu Li (32 shared papers)Wei Xiong (26 shared papers)Qianjin Liao (23 shared papers)Zhaojian Gong (20 shared papers)Weiwei Tang (7 shared papers)Ming Zhou (18 shared papers)
- Journals
- Oncotarget (5 papers)PLoS ONE (4 papers)Frontiers in Oncology (4 papers)Journal of Clinical Laboratory Analysis (3 papers)International Immunopharmacology (3 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Wenling Zhang
136 papers receiving 5.1k citations
Wenling Zhang's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 2.1k
- Molecular Biology 3.1k
- Oncology 781
- Immunology 525
- Periodontics 105
Countries citing papers authored by Wenling Zhang
This map shows the geographic impact of Wenling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenling Zhang more than expected).
Fields of papers citing papers by Wenling Zhang
This network shows the impact of papers produced by Wenling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenling Zhang. The network helps show where Wenling Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenling Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects Hit paper breakdown → | 2020 | 789 |
| 2 | 2017 | 308 | |
| 3 | 2015 | 190 | |
| 4 | 2000 | 150 | |
| 5 | 2015 | 134 | |
| 6 | 2017 | 133 | |
| 7 | 2006 | 131 | |
| 8 | 2015 | 128 | |
| 9 | 2010 | 126 | |
| 10 | 2000 | 105 | |
| 11 | 2015 | 101 | |
| 12 | 2008 | 96 | |
| 13 | 2012 | 95 | |
| 14 | 2014 | 94 | |
| 15 | 2018 | 85 | |
| 16 | 2023 | 85 | |
| 17 | 2022 | 84 | |
| 18 | 2016 | 81 | |
| 19 | 2016 | 80 | |
| 20 | 2017 | 74 |
About Wenling Zhang
Wenling Zhang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 145 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (25 papers), RNA modifications and cancer (18 papers), MicroRNA in disease regulation (12 papers), RNA Research and Splicing (10 papers), Viral-associated cancers and disorders (9 papers), Circular RNAs in diseases (7 papers), Cancer-related gene regulation (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (3.1k citations), Oncology (781 citations), Immunology (525 citations) and Periodontics (105 citations). Wenling Zhang has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Zhaoyang Zeng, Xiayu Li, Wei Xiong, Qianjin Liao, Zhaojian Gong, Weiwei Tang, Ming Zhou, Bo Xiang and Dawei Rong. Their work appears in journals such as Oncotarget, PLoS ONE, Frontiers in Oncology, Journal of Clinical Laboratory Analysis and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.